logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10633394 B1

PDFFull Text
Date of Patent:
Apr. 28, 2020

Filed:

Nov. 30, 2015

Heterocyclic derivatives and use thereof

Applicant:

C & C Research Laboratories, Suwon-si, Gyeonggi-do, KR;

Inventors:

Chan Hee Park, Suwon-si, KR;

Sang Hwi Lee, Suwon-si, KR;

Junhwan Im, Suwon-si, KR;

Soon Ok Lee, Suwon-si, KR;

Jungsook Kim, Suwon-si, KR;

Heon Kyu Park, Suwon-si, KR;

Jee Hun Yun, Suwon-si, KR;

Kwang Seok Ko, Suwon-si, KR;

Hye Jung Kim, Suwon-si, KR;

Byungho Kim, Suwon-si, KR;

Mi Sun Kim, Suwon-si, KR;

Minjung Kong, Suwon-si, KR;

Hyung Jo Moon, Suwon-si, KR;

Assignee:

C&C RESEARCH LABORATORIES, Suwon-si, KR;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Taofiq A Solola

Int. Cl.
CPC ...
C07D 498/04 (2006.01); C07D 413/14 (2006.01); C07D 333/70 (2006.01); C07D 409/04 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/06 (2006.01); C07D 209/42 (2006.01); C07D 487/04 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/10 (2006.01); C07D 495/04 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); A61P 35/00 (2018.01); C07D 209/42 (2013.01); C07D 333/70 (2013.01); C07D 409/04 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/06 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/10 (2013.01); C07D 495/04 (2013.01);
Abstract

A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.

Find Patent Forward Citations

Loading…